Svitlana Kurinna

Svitlana Kurinna

Auto-generated profile, based on publicly available information

Svitlana Kurinna

Faculty of Biology. Medicine and Health Manchester Greater Manchester M13 9PT University of Manchester

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2014 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
MSMatthias Schäfer
Matthias Schäfer
AWAnn‐Helen Willrodt
Ann‐Helen Willrodt
SKSvitlana Kurinna
Svitlana Kurinna
ALAndrea S Link
Andrea S Link
HFHany Farwanah
Hany Farwanah
SWSabine Werner
Sabine Werner
The transcription factor Nrf2 is a key regulator of the cellular stress response, and pharmacological Nrf2 activation is a promising strategy for skin protection and cancer prevention. We show here that prolonged Nrf2 activation in keratinocytes causes sebaceous gland enlargement and seborrhea in mice due to upregulation of the growth factor epigen, which we identified as a novel Nrf2 target. This was accompanied by thickening and hyperkeratosis of hair follicle infundibula. These abnormalities caused dilatation of infundibula, hair loss, and cyst development upon aging. Upregulation of epigen, secretory leukocyte peptidase inhibitor (Slpi), and small proline‐rich protein 2d (Sprr2d) in hair follicles was identified as the likely cause of infundibular acanthosis, hyperkeratosis, and cyst formation. These alterations were highly reminiscent to the phenotype of chloracne/“metabolizing acquired dioxin‐induced skin hamartomas” (MADISH) patients. Indeed, SLPI, SPRR2, and epigen were strongly expressed in cysts of MADISH patients and upregulated by dioxin in human keratinocytes in an NRF2‐dependent manner. These results identify novel Nrf2 activities in the pilosebaceous unit and point to a role of NRF2 in MADISH pathogenesis.

8 January 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
SKSvitlana Kurinna
Svitlana Kurinna
SSSabrina A. Stratton
Sabrina A. Stratton
ZCZeynep Coban
Zeynep Coban
JSJill M. Schumacher
Jill M. Schumacher
MGMarkus Grompe
Markus Grompe
MBMichelle Craig Barton
Michelle Craig Barton
Functions of p53 during mitosis reportedly include prevention of polyploidy and transmission of aberrant chromosomes. However, whether p53 plays these roles during genomic surveillance in vivo and, if so, whether this is done via direct or indirect means remain unknown. The ability of normal, mature hepatocytes to respond to stimuli, reenter the cell cycle, and regenerate liver mass offers an ideal setting to assess mitosis in vivo . In quiescent liver, normally high ploidy levels in adult mice increased with loss of p53. Following partial hepatectomy, p53−/− hepatocytes exhibited early entry into the cell cycle and prolonged proliferation with an increased number of polyploid mitoses. Ploidy levels increased during regeneration of both wild-type (WT) and p53−/− hepatocytes, but only WT hepatocytes were able to dynamically resolve ploidy levels and return to normal by the end of regeneration. We identified multiple cell cycle and mitotic regulators, including Foxm1 , Aurka , Lats2 , Plk2 , and Plk4 , as directly regulated by chromatin interactions of p53 in vivo . Over a time course of regeneration, direct and indirect regulation of expression by p53 is mediated in a gene-specific manner. Conclusion : Our results show that p53 plays a role in mitotic fidelity and ploidy resolution in hepatocytes of normal and regenerative liver.

1 November 2004 in Cancer Research
Verified
Journal Article
Closed access
SKSvitlana M. Kurinna
Svitlana M. Kurinna
CTChun Chui Tsao
Chun Chui Tsao
ANAlina Felicia Nica
Alina Felicia Nica
TJTilahun Jiffar
Tilahun Jiffar
PRPeter P. Ruvolo
Peter P. Ruvolo
Ceramide regulates diverse signaling pathways involving cell senescence, the cell cycle, and apoptosis. Ceramide is known to potently activate a number of stress-regulated enzymes, including the c-Jun NH2-terminal kinase (JNK). Although ceramide promotes apoptosis in human lung cancer-derived A549 cells, a role for JNK in this process is unknown. Here, we report that ceramide promotes apoptosis in A549 cells by a mechanism involving JNK. The JNK inhibitor SP600125 proved effective at protecting cells from the lethal effects of ceramide. To understand which JNK-mediated pathway may be involved, a number of JNK target proteins were examined, including the transcription factor, c-Jun, and the apoptotic regulatory proteins Bcl-XL and Bim. A549 cells exhibited basal levels of phosphorylated c-Jun in nuclear fractions, revealing that active c-Jun is present in these cells. Ceramide was found to inhibit c-Jun phosphorylation, suggesting that JNK-mediated phosphorylation of c-Jun is not likely involved in ceramide-induced apoptosis. Ceramide did not promote Bcl-XL phosphorylation. On the other hand, ceramide promoted phosphorylation of Bim and induced translocation of active JNK from the nucleus to the cytoplasm and mitochondrial fraction. Ceramide-mediated changes in localization of JNK were consistent with the observed changes in phosphorylation status of c-Jun and Bim. Furthermore, ceramide promoted Bim translocation to the mitochondria. Mitochondrial localization of Bim has been shown recently to promote apoptosis. These results suggest that JNK may participate in ceramide-induced apoptosis in A549 cells by a mechanism involving Bim.

6 December 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
UKUlrike A. Köhler
Ulrike A. Köhler
SKSvitlana Kurinna
Svitlana Kurinna
DSDominik Schwitter
Dominik Schwitter
AMAndrea Marti
Andrea Marti
MSMatthias Schäfer
Matthias Schäfer
SWSabine Werner
Sabine Werner
The nuclear factor erythroid-derived 2, like 2 (Nrf2) transcription factor is a key regulator of the antioxidant defense system, and pharmacological activation of Nrf2 is a promising strategy for prevention of toxin-induced liver damage. However, the consequences of Nrf2 activation on liver regeneration (LR) have not been determined. To address this question, we generated mice expressing a constitutively active Nrf2 (caNrf2) mutant in hepatocytes. Expression of the transgene did not affect liver homeostasis. Surprisingly, however, there was no beneficial effect of Nrf2 activation on CCl4-induced liver injury and fibrosis. Most important, LR after partial hepatectomy was impaired in caNrf2-transgenic mice as a result of delayed hepatocyte proliferation and enhanced apoptosis of these cells after liver injury. Mechanistically, this involved up-regulation of the cyclin-dependent kinase inhibitor p15 and the proapoptotic protein Bcl2l11 (Bim). Using chromatin immunoprecipitation, we show that the p15 and Bcl2l11 genes are direct targets of Nrf2, which are activated under hyperproliferative conditions in the liver. Conclusion: Activated Nrf2 delays proliferation and induces apoptosis of hepatocytes in the regenerating liver. These negative effects of Nrf2 activation on LR should be considered when Nrf2-activating compounds are used for prevention of liver damage. (Hepatology 2014;60:670–678)

22 January 2004 in Leukemia
Verified
Journal Article
Closed access
PDF file
TJT Jiffar
T Jiffar
SKS Kurinna
S Kurinna
GSG Suck
G Suck
DCD Carlson-Bremer
D Carlson-Bremer
MRM R Ricciardi
M R Ricciardi
PRP P Ruvolo
P P Ruvolo

6 October 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSvitlana Kurinna
Svitlana Kurinna
MSMatthias Schäfer
Matthias Schäfer
POPaola Ostano
Paola Ostano
EKEmmanuel Karouzakis
Emmanuel Karouzakis
GCGiovanna Chiorino
Giovanna Chiorino
SWSabine Werner
Sabine Werner
The Nrf2 transcription factor controls the expression of genes involved in the antioxidant defense system. Here, we identified Nrf2 as a novel regulator of desmosomes in the epidermis through the regulation of microRNAs. On Nrf2 activation, expression of miR-29a and miR-29b increases in cultured human keratinocytes and in mouse epidermis. Chromatin immunoprecipitation identified the Mir29ab1 and Mir29b2c genes as direct Nrf2 targets in keratinocytes. While binding of Nrf2 to the Mir29ab1 gene activates expression of miR-29a and -b, the Mir29b2c gene is silenced by DNA methylation. We identified desmocollin-2 (Dsc2) as a major target of Nrf2-induced miR-29s. This is functionally important, since Nrf2 activation in keratinocytes of transgenic mice causes structural alterations of epidermal desmosomes. Furthermore, the overexpression of miR-29a/b or knockdown of Dsc2 impairs the formation of hyper-adhesive desmosomes in keratinocytes, whereas Dsc2 overexpression has the opposite effect. These results demonstrate that a novel Nrf2-miR-29-Dsc2 axis controls desmosome function and cutaneous homeostasis.